Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
0.974 USD | -0.39% | +4.87% | -32.63% |
05-07 | Transcript : Rigel Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 07, 2024 | |
05-07 | Earnings Flash (RIGL) RIGEL PHARMACEUTICALS Posts Q1 Revenue $29.5M, vs. Street Est of $31.5M | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.63% | 172M | |
+14.62% | 118B | |
+13.39% | 106B | |
-2.02% | 24.28B | |
+0.67% | 21.96B | |
-9.37% | 18.16B | |
-42.28% | 16.37B | |
-17.24% | 15.56B | |
+6.12% | 13.63B | |
+29.44% | 12.27B |
- Stock Market
- Equities
- RIGL Stock
- News Rigel Pharmaceuticals, Inc.
- Rigel Pharmaceuticals, Inc. Provides Operating Guidance for the Third Quarter of 2021